Sandoz biosimilar filgrastim recommended for approval by FDA Oncologic Drugs Advisory Committee
Oncologic Drugs Advisory Committee (ODAC) votes in favor of recommending biosimilar filgrastim for approval in the USBiosimilar filgrastim recommended to be approved for use in all requested indicationsCommittee’s recommendation based on review of exte…